Perioperative management of primary liver cancer

Table 1 Operation approach for patients in two groups

Operative approach	Earlier periodgroup (%)	Later periodgroup (%)
Resection group
Right trisectionectomy	6 (0.8)	19 (1.3)
Right hepatectomy	82 (11.2)	73 (5.2)
Right posterior sectionectomy	26 (3.6)	125 (8.9)
Right anterior sectionectomy	13 (1.8)	131 (9.3)
Middle sectionectomy	11 (1.5)	44 (3.1)
Left trisectsanectomy	8 (1.1)	24 (1.7)
Left hepatectomy	27 (3.7)	129 (9.1)
Left lateral sectionectomy	31 (4.2)	88 (6.2)
Candate lobectomy	5 (0.7)	38 (2.7)
Segmentectomy	103 (14.1)	306 (21.7)
Total	312 (42.7)	977 (69.2)
Non-resection group
Hepatic artery ligation or pump	251 (34.3)	143 (10.1)
Intro arterial 131I resin form embolization	96 (13.1)	49 (3.5)
Intro-arterial 32P-GMS embolization1	28 (3.8)	36 (2.5)
Cryosurgical ablation	24 (3.3)	82 (5.8)
Radiofrequancy ablation	0 (0)	102 (7.2)
Laparotomy	20 (2.7)	23 (1.6)
Total	419 (57.3)	435 (30.8)

¹32P-GMS: Phosphorus 32 glass microspheres; ΔRFA: Radiofrequancy ablation.

Table 2 Comparison of mortality, complication, and survival rate in two groups after hepatectomy (%)

Group	Operativemortality	Complication rate	Survival rate
			1 yr	3 yr	5 yr
Earlier period group	2.2	23.7	73.1	54.2	34
Later period group	1.4	20.3	84.9	61.1	38.7